FoxHollow treats first patients with arterial plaque removal technology

By Lisa Kerner

Charlotte, N.C., Sept. 8 - FoxHollow Technologies, Inc. said the first five patients have been treated with its new NightHawk technology that removes plaque from blocked arteries in the lower legs.

NightHawk combines onboard real-time imaging with FoxHollow's Food and Drug Administration-approved SilverHawk Plaque Excision System.

A team of U.S. interventional cardiologists, including FoxHollow chief executive officer John Simpson, oversaw the treatment conducted at the American Heart of Poland Hospital in Bielsko.

"These initial procedures with the NightHawk, although early-stage, are very encouraging and consistent with our experience in pre-clinical studies," Simpson said in a news release.

FoxHollow, based in Redwood City, Calif., develops minimally invasive plaque excision devices.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.